A Single-dose, Dose-escalation Study of a Long-acting MOD-5014 in Healthy Adult Male

NCT02919800 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A or B With Inhibitors

Interventions

BIOLOGICAL: MOD-5014
OTHER: MOD-5014 Placebo

Sponsor

OPKO Health, Inc.